CARDIACSENSE Cardiacsense (approximately 5.67%), Receives CE approval for the marketing of a medical watch that it opened in Europe, expected date for FDA approval Post published:10/02/2021
CDX The investment of $ 150k as part of an investment round of about $ 17k in CDX according to about $ 112k (after), will hold 6.64% Post published:07/02/2021
CARDIACSENSE A round of fundraising in Cardiacsense (about 5.8%) – the debtor will invest $ 250, hold about 5.95% of the capital, B. Control will participate Post published:04/02/2021
EFA EFA (approximately 7.9%), began an experiment in collaboration with Maccabi and the Medical Campus to validate the data reported by the RevDx device developed by it Post published:31/01/2021
MERCHAVIA Update call details and telephone conference for the special general meeting to be held today (19.1.21) Post published:19/01/2021
pdf1 Ora Air (approx. 1.93%) in an exclusive distribution agreement for its products in Taiwan and Vietnam Post published:18/01/2021
MERCHAVIA Binding investment agreement with Ocon Medical, the company will invest $ 350m in an investment round of about $ 1.5m in exchange for an allocation from Ocon Medical. Post published:03/01/2021
MERCHAVIA Nervio investment agreement signed, will invest up to NIS 650,000 against 6% in Nervio, an option for additional investment Post published:30/12/2020
